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Reverse cholesterol transportStAR family proteins in vascular macrophages participate in reverse cholesterol transport (RCT). We
hypothesize that under pathophysiological oxidative stress, StARs will transport not only cholesterol
to macrophage mitochondria, but also pro-oxidant cholesterol hydroperoxides (7-OOHs), thereby
impairing early-stage RCT. Upon stimulation with dibutyryl-cAMP, RAW264.7 macrophages
exhibited a strong time-dependent induction of mitochondrial StarD1 and plasma membrane
ABCA1, which exports cholesterol. 7a-OOH uptake by stimulated RAW cell mitochondria (like
cholesterol uptake) was strongly reduced by StarD1 knockdown, consistent with StarD1
involvement. Upon uptake by mitochondria, 7a-OOH (but not redox-inactive 7a-OH) triggered lipid
peroxidation and membrane depolarization while reducing ABCA1 upregulation. These ﬁndings
provide strong initial support for our hypothesis.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Expression of scavenger receptors such as SR-B1 and CD36 by
vascular macrophages is not regulated by cholesterol negative
feedback [1]. Consequently, under conditions of oxidative stress,
these cells could potentially become engorged with cholesterol
and other lipids due to unregulated uptake of oxidized low density
lipoprotein (oxLDL) [2]. Export to HDL is a key step in reverse
cholesterol transport (RCT) by which macrophages limit or reverse
deleterious lipid accumulation [3,4]. If export capacity is impaired
or overwhelmed, macrophages can be transformed to lipid-laden
‘‘foam cells’’, which accumulate in the vascular wall and contributeto atherogenesis [2–4]. In addition to plasma membrane scavenger
receptors, macrophages express other proteins that play crucial
roles in inward/outward cholesterol trafﬁcking. These include
steroidogenic acute regulatory (StAR) family proteins, which bind
preexisting or incoming cholesterol and deliver it to/into mito-
chondria for conversion to 27-hydroxycholesterol (27-OH) by the
CYP27A1 system [5,6]. Most StAR proteins contain a START domain
pocket which accommodates a single cholesterol molecule in
highly speciﬁc fashion, i.e. with little (if any) recognition of non-
sterol lipids [7]. 27-OH is a key agonist of liver-X-receptor (LXR)
transcription factors, which, upon interacting with retinoid-X-
receptor in the nucleus, induce expression of the plasma mem-
brane ATP-binding cassette transporters ABCA1 and ABCG1 [8,9].
These proteins play crucial roles in exporting excess cholesterol
to extracellular acceptors, ABCA1 sending it mainly to apoA1, the
lipid-free/poor protein of HDL [8]. Cholesterol loading or 8-Br-
cAMP treatment of mouse or human macrophages induces several
regulatory proteins, including StarD1 and CYP27A1, resulting in
27-OH formation and elevated cholesterol efﬂux to re-establish
homeostasis [10]. Mature StarD1, found in the mitochondrial outer
membrane, participates in cholesterol transport to the inner
membrane for processing by CYP27A1. StarD4, a structural
homologue of StarD1 that lacks organelle-targeting sequences,
probably functions as a cytosolic cholesterol transporter [6,11].
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stress can be converted to various oxides, including redox-active
hydroperoxides ChOOHs) such as 7a- and 7b-OOH [12]. Like all
lipid hydroperoxides, ChOOHs are subject to (i) iron-catalyzed
one-electron reduction to oxidizing free radicals or (ii) enzyme-
catalyzed two-electron reduction to redox-inert alcohols [12]. If
pathway (i) predominates, it may expand oxidative damage by
triggering chain lipid peroxidation. Studies in this laboratory [13]
have revealed that ChOOHs may also undergo spontaneous or
transfer protein-enhanced translocation to membrane or lipopro-
tein acceptors, where processes (i) or (ii) may ensue. Translocation
may result in the ‘‘broadcasting’’ of ChOOH toxicity or redox
signaling [13]. In support of this idea, we showed previously that
membrane depolarization of isolated mitochondria during expo-
sure to 7a-OOH was enhanced by SCP-2, a non-speciﬁc lipid trans-
fer protein [14]. 7a-OOHwas subsequently shown to be more toxic
to SCP-2-overexpressing cells than to controls, and this correlated
with greater 7a-OOH uptake, one-electron turnover in mitochon-
dria, and loss of membrane potential [15]. Turning more recently
to sterol-speciﬁc StAR family proteins, we showed that recombi-
nant StarD4 accelerated membrane-damaging transfer of 7a-OOH
to isolated mitochondria, whereas it had no effect on phosphatidyl-
choline hydroperoxide transfer [16].
The goal of this study was to test the novel hypothesis that un-
der oxidative stress associated, for example, with chronic obesity
and atherogenesis, StAR proteins transport not only cholesterol
to macrophage mitochondria, but also ChOOHs, which trigger
site-speciﬁc peroxidative damage that impairs RCT at its early
stages.
2. Materials and methods
2.1. General materials
Sigma–Aldrich (St. Louis, MO) supplied the cholesterol, db-
cAMP, MTT, JC-1, and fetal bovine serum. C11-BODIPY was from
Molecular Probes (Eugene, OR). POPC and 7a-OH were from Avanti
Polar Lipids (Birmingham, AL). Boehringer Mannheim (Indianapo-
lis, IN) supplied the Complete-Mini mixture of protease inhibitors.
Primary antibodies against mouse StarD1, StarD4, ABCA1, and
human b-actin were from Santa Cruz Biotechnology (Santa Cruz,
CA). A horseradish peroxidase-conjugated IgG secondary antibody
was from Cell Signaling Technology (Danvers, MA). Amersham
Biosciences (Arlington Heights, IL) supplied the [4-14C]cholesterol
(50 mCi/ml). 7a-OOH was prepared by dye-sensitized photoper-
oxidation of cholesterol, as described [17]; [14C]7a-OOH was
prepared similarly, using [4-14C]cholesterol.
2.2. Cell culture, stimulation, and challenge
Mouse RAW264.7macrophages (ATCC)were cultured in humid-
iﬁed 5% CO2, 95% air at 37 C in DME medium supplemented with
10% fetal bovine serum, penicillin (100 units/ml), and streptomycin
(0.1 mg/ml). Prior to an experiment, cells at 70% conﬂuency were
incubated for up to 16 h at 37 C in DME medium that either con-
tained 1.0 mM db-cAMP or lacked it. After this incubation, where
indicated, cells were washed again and exposed to small (50-nm)
unilamellar liposomes (SUVs) composed of POPC/cholesterol (1:1
by mol), POPC/cholesterol/7a-OH (1:0.8:0.2 by mol), or POPC/cho-
lesterol/7a-OOH (1:0.8:0.2 by mol) in DME medium.
2.3. StarD1 knockdown
Silencer siRNAs for mouse StarD1 and scrambled oligonucleo-
tide pairs were purchased from Ambion (Austin, TX). Singletransfections of duplex mixtures were carried out in OPTI-MEM
medium (Gibco/Life Technologies, Grand Island, NY) for 8 h, using
X-tremeGENE (18 ll/ml) as advised by the supplier (Roche
Diagnostics, Indianapolis, IN). Following transfection, cells were
switched to full growth medium without siRNA or X-tremeGENE
for a 36–48 h recovery period, then washed, overlaid with DME
medium, and stimulated with 1 mM db-cAMP for 9–12 h. After
this, they were either challenged with SUV-7a-OOH or scraped
into ice-cold protease inhibitor-containing PBS and analyzed for
StarD1, StarD4, and ABCA1 expression by Western blotting [18].
2.4. Determination of mitochondrial uptake of 7a-OOH
Mitochondrial uptake of 7a-OOH, was determined essentially
as described [18]. Brieﬂy, stimulated or non-stimulated wild type
(WT) and knockdown (kd) cells were incubated in serum-free RPMI
medium with 50 mM [14C]7a-OOH in POPC/cholesterol/7a-OOH
SUVs for up to 5 h. Following incubation, cells were washed,
scraped into ice-cold PBS, and pelleted by centrifugation.
Mitochondria were isolated by differential centrifugation [18],
quantiﬁed by BCA protein assay, and subjected to scintillation
counting.
2.5. Measurement of mitochondrial membrane potential (DWm)
WT and kd cells in black-wall 96-well plates were either un-
treated or stimulated with 1 mM db-cAMP in DME medium for
9 h, and exposed to SUV-7a-OOH in either increasing concentra-
tions (10–100 lM) for a ﬁxed time (5 h), or 100 lM SUV-7a-OOH
for increasing times up to 7 h. After peroxide exposure, cells were
washed, incubated with JC-1 (5 lg/ml) for 30 min, washed again,
and analyzed using a BioTek Synergy-MX ﬂuorescence plate reader
(Winooski, VT). Settings were as follows: red (kex 560 nm; kem
595 nm); green (kex 485 nm; kem 535 nm).
2.6. Assessment of 7a-OOH-induced lipid peroxidation and cell death
Cells grown on FlexiPERM slides (Sarstedt, Numbrecht, Ger-
many) in glass-bottom dishes were stimulated for 9 h with 1 mM
db-cAMP, then treated with 2 lM C11-BODIPY for 30 min at
37 C. Non-stimulated control cells were treated alongside. All cells
were then incubated with 25 lM SUV-7a-OOH for 4 h or 50 lM
SUV-7a-OOH for 2.5 h, then washed, overlaid with RPMI medium,
and examined by confocal ﬂuorescence microscopy, using a Leica
TCS SESII instrument with 488 nm excitation and 607–680 nm
(red) or 500–585 nm (green) emission to observe unoxidized and
oxidized probe, respectively [19].
For assessing viability, cells were pre-incubated with or without
db-cAMP for 3 h, then either left untreated (control) or incubated
with liposomal 7a-OOH in increasing concentrations up to 50 lM
for an additional 18 h. After incubation, cell viability was assessed
by MTT (thiazolyl blue) assay [15].
3. Results
3.1. StarD1, StarD4, and ABCA1 expression in cAMP-stimulated cells:
effect of StarD1-kd on ABCA1
We asked ﬁrst how RAW cell stimulation with db-cAMP would
affect expression of StarD1, StarD4, and ABCA1 proteins. StarD1
and StarD4 were detected in resting cells, but ABCA1 was barely
detectable (Fig. 1A). StarD1 increased progressively during db-
cAMP treatment, reaching about twice its starting level after 9 h.
StarD4 was also upregulated, attaining 2.5-times its starting level
after 9 h. Non-stimulated cells showed no change in StarD1 or
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Fig. 1. StarD1, StarD4, and ABCA1 expression in db-cAMP-activated RAW cells:
effects of siRNA-based StarD1 knockdown. (A) Cells at 60–70% conﬂuency in serum-
free DME medium were incubated with 1 mM db-cAMP for up to 16 h, after which
cells were collected, lysed, and subjected to Western analysis for the three proteins
along with b-actin as a loading control. Numbers below lanes represent band
intensities normalized to b-actin and relative to 0 h. (B) StarD1 and (C) ABCA1 level
at 16 h in wild-type, scrambled siRNA-, and siRNA-treated cells. Total protein load:
60 lg/lane.
Fig. 2. 7a-OOH uptake by mitochondria in stimulated vs non-stimulated RAW
cells; effects of StarD1 knockdown. Wild-type (WT), scrambled siRNA (Scr), and
knockdown siRNA (kd) cells stimulated (S) with 1 mM db-cAMP for 9 h in serum-
free RPMI, along with a non-stimulated (NS) WT control, were incubated with
50 lM [14C]7a-OOH in POPC/cholesterol/[14C]7a-OOH (1.0:0.8:0.2 by mol) SUVs for
the indicated times, after which cells were washed and homogenized. Mitochondria
were isolated by differential centrifugation and analyzed by scintillation counting.
(d) WT-S; (N) Scr-S; (.) kd-S; (s) WT-NS. Means ± S.E. of values from three
replicate experiments are plotted.
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dramatic upregulation in ABCA1 during db-cAMP treatment, its
level after 21 h being more than 40-times above basal (Fig. 1A).
StarD1 knockdown (kd) was used to conﬁrm this protein’s involve-
ment in RCT [6] and to assess its role in 7a-OOH trafﬁcking. StarD1
level after sequential siRNA and db-cAMP treatment of RAW cells
was 50% that of scrambled control or wild-type cells (Fig. 1B).
Signiﬁcantly, ABCA1 upregulation during cell stimulation was also
diminished by StarD1-kd (Fig. 1C), suggesting that StarD1 can reg-
ulate ABCA1 expression [6].
3.2. Effect of cell stimulation and StarD1-kd on mitochondrial uptake
of 7a-OOH
Knowing that macrophage stimulation with 8-Br-cAMP or db-
cAMP enhances cholesterol uptake and export [6,8,9], we asked
whether such stimulation would also enhance uptake of 7a-OOH
when presented to cells together with cholesterol. As shown in
Fig. 2 mitochondria in db-cAMP-stimulated wild-type RAW cells
incorporated SUV-supplied [14C]7a-OOH more rapidly than those
in non-stimulated controls such that after 6 h, the former con-
tained nearly twice the radioactivity of the latter. Upregulated
StarD1 played an important role in the more rapid uptake because
StarD1-kd (Fig. 1B) resulted in a substantial slowdown in [14C]7a-
OOH uptake, its level at 6 h being only 67% that of a scrambled
siRNA or wild-type control (Fig. 2). Similar effects of StarD1-kd
were observed for [14C]cholesterol uptake by stimulated cell mito-
chondria (not shown), which is consistent with previous ﬁndings
[6,10]. These results clearly demonstrate that StarD1 can transport
not only cholesterol into RAW cell mitochondria, but also 7a-OOH.
3.3. 7a-OOH-induced lipid peroxidation in stimulated vs non-
stimulated cells
The membrane-localizing ratiometric ﬂuorophore C11-BODIPY
can report on free radical-mediated lipid peroxidation that may oc-
cur in its midst. Accordingly, we used this probe to assess whether
7a-OOH internalized by RAW cell mitochondria would initiate
lipid peroxidative damage. When exposed to 25 lM SUV-7a-OOH
for 4 h, stimulated cells exhibited less red ﬂuorescence (nativeprobe) and more green ﬂuorescence (oxidized probe) than non-
stimulated counterparts (Fig. 3A). After 2.5 h with 50 lM SUV-
7a-OOH, lipid peroxidation was more advanced overall, but still
more intense in stimulated vs non-stimulated cells. Thus, greater
7a-OOH uptake by mitochondria of stimulated cells (Fig. 2) re-
sulted in more extensive peroxidative damage and, as expected,
this appeared to be localized mainly in mitochondria (punctate
perinuclear zones). Integrated values for the ﬂuorescence signals
shown in Fig. 3A are plotted in Fig. 3B as relative (red/green) ﬂuo-
rescence intensities.
3.4. Effect of 7a-OOH on DWm of stimulated wild-type vs. StarD1-kd
cells
Mitochondria damage/dysfunction is commonly reﬂected in a
loss of transmembrane potential (DWm). We used the potentio-
metric probe JC-1 to assess DWm status of stimulated vs non-stim-
ulated RAW cells after a 7a-OOH challenge. As shown in Fig. 4A,
non-stimulated cells exposed for 5 h to SUV-7a-OOH in increasing
concentrations up to 100 lM exhibited an initial (highly reproduc-
ible) increase in DWm at 20 lM peroxide followed by a rapid de-
cline, reaching complete depolarization at 50 lM peroxide. In
striking contrast, stimulated cells treated identically exhibited an
immediate decline in DWm with increasing 7a-OOH, the nadir in
this case occurring at 30 lM hydroperoxide (Fig. 4A). However,
7a-OH, the redox-inactive reduction product of 7a-OOH, had no
effect on DWm (Fig. 4A) even though it was delivered into stimu-
lated cell mitochondria at the same rate as 7a-OOH (data not
shown). Thus, upon arrival in mitochondria (Fig. 2), 7a-OOH
underwent free radical turnover, thereby triggering peroxidative
damage (Fig. 3) and functional impairment. We established that
StarD1 was required for hydroperoxide-induced mitochondria
depolarization by showing that time-dependent DWm loss pro-
duced by 100 lM SUV-7a-OOH was substantially slowed by
StarD1-kd (Fig. 4B).
3.5. Effect of 7a-OOH on StarD1 and ABCA1 expression in stimulated
cells
Knowing that StarD1 and ABCA1 synthesis depends on







Fig. 3. Lipid peroxidation induced by intracellular 7a-OOH trafﬁcking. (A) Non-
stimulated and stimulated cells (1 mM db-cAMP, 9 h) in DMEM medium were
incubated with 25 lM 7a-OOH from POPC/cholesterol/7a-OOH (2.5:1.5:1.0 by mol)
SUVs for 4 h or 50 lM 7a-OOH from the same SUVs for 2.5 h. Cells were then
washed, treated with 2 lM C11-BODIPY for 30 min, and examined by confocal
ﬂuorescence microscopy, using settings described in the Section 2. (B) Fluorescence
intensity ratio (green/red) plotted as a function of 7a-OOH concentration for cell
images shown in (A); at least 100 cells in 5–6 viewing ﬁelds are represented in each
bar. P < 0.05; P < 0.01.
Fig. 4. Effects of 7a-OOH and 7a-OH onDWm of stimulated vs non-stimulated RAW
cells; consequences of StarD1-kd. (A) Wild-type cells in serum-free medium were
either not stimulated (NS) or stimulated (S) with 1 mM db-cAMP for 9 h and then
incubated with SUV-7a-OOH [(s) NS; (d) S] or SUV-7a-OH [ (h) NS; (j) S] in
increasing concentrations up to 100 lM for 5 h. (B) Stimulated StarD1-kd (.) and
scrambled siRNA control (N) cells were incubated with 100 lM SUV-7a-OOH for
increasing times up to 7 h. After incubation, cells in (A) and (B) were washed,
treated with JC-1 (5 lg/ml) for 30 min, washed again, and examined by ﬂuores-
cence plate reader, using the following settings: 560 nm ex/595 nm em (red) and
485 nm ex/535 nm em (green). Data are plotted as ﬂuorescence intensity ratios
(RFI: 595 nm/535 nm); means ± S.E. of values from 3–4 replicate experiments are
represented.
Fig. 5. Effect of 7a-OOH uptake on StarD1 and ABCA1 expression. RAW cells at 60–
70% conﬂuency in DME medium were activated for 9 h with 1 mM db-cAMP, then
washed and incubated with 100 lM SUV-7a-OOH. At the indicated times, cells
were washed, retrieved, lysed and subjected toWestern blot analysis for StarD1 and
ABCA1. Protein bands were integrated and b-actin-normalized values were plotted
relative to starting values (0 h). P < 0.01 compared with 0-time value.
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steady state levels of these proteins. As shown in Fig. 5, exposing
9 h-stimulated RAW cells to 100 lM SUV-7a-OOH resulted in sig-
niﬁcant decreases in StarD1 and ABCA1 levels (25% and 50%,
respectively), but these were observed after a relatively long incu-
bation time of 6 h. This suggests that loss of antibody-recognizing
epitopes was not primarily responsible for these decreases, but
rather impaired mitochondrial ATP generation and/or 27-OH pro-
duction in the case of ABCA1 [8].
3.6. Effect of cell stimulation on 7a-OOH toxicity
In the experiments represented in Figs. 2–5, RAW cells
incubated with up to 100 lM SUV-7a-OOH for up to 6 h showed
no signiﬁcant viability losses, but these became more apparent
with longer incubation. As shown in Fig. 6, stimulated cells ex-
posed to 10 lM or 50 lM SUV-7a-OOH for 18 h exhibited an
MTT-assessed loss of viability that was signiﬁcantly greater than
that of non-stimulated controls. Preliminary experiments revealed
that stimulated cell death occurred mainly via intrinsic apoptosis
(results not shown), consistent with the mitochondria-targeted
oxidative stress represented in Figs. 3 and 4. Thus, 7a-OOH
Fig. 6. Effect of cell stimulation on 7a-OOH cytotoxicity. RAW cells in DMEM
medium were either not stimulated or stimulated with 1 mM cb-cAMP for 3 h, then
challenged with POPC/cholesterol/7a-OOH (1.0:0.8:0.2 by mol) SUVs at the
indicated bulk phase concentration of 7a-OOH. After 16 h of incubation, cell
viability was assessed by MTT (thiazolyl blue) assay. Means ± S.E. of values from 3–
4 separate experiments are plotted relative to non-challenged controls.
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of stimulated RAW cells and this eventually culminated in apopto-
tic cell death.
4. Discussion
LDL contains numerous unsaturated lipids, including free cho-
lesterol and cholesteryl esters, and is thus susceptible to oxidative
modiﬁcation in the circulation [12,17]. Most prominent among the
cholesterol oxidation products are the ChOOHs 7a- and 7b-OOH,
the diols 7a- and 7b-OH, the 7-ketone, and 5,6-epoxides [12].
Depending on levels and location, these oxysterols can act as
cytotoxic and/or signaling molecules, but only 7a/7b-OOH are
redox-active, i.e. capable of inducing peroxidative damage via
one-electron reductive turnover [12,13]. In the process, these
hydroperoxides are converted to 5,6-epoxides, 7a/7b-OH, and 7-
ketone. Modiﬁcation of LDL apoB-100 protein by 4-hydroxynone-
nal and other by-products of lipid peroxidation results in a particle
(LDLox) which is more readily taken up by macrophages via scaven-
ger receptors [1]. Uncontrolled uptake and insufﬁcient cholesterol
export by macrophages can result in formation of lipid-loaded
‘‘foam cells’’ that accumulate in the vascular wall. This is regarded
as a key early event in atherogenesis and it can be exacerbated by
oxidative stress associated with disorders such as chronic obesity
and hypertension [2].
In this study, we have shown for the ﬁrst time that 7a-OOH,
which has been identiﬁed in human LDLox and atherosclerotic pla-
ques [20,21], can be trafﬁcked to/into mitochondria of db-cAMP-
activated RAW264.7 macrophages similarly to cholesterol, thereby
causing lipid peroxidative damage, membrane depolarization,
metabolic impairment that reduces StarD1 and ABCA1 expression,
and ultimately apoptotic cell death. In ongoing studies, similar
observations have been made on human THP-1 macrophages
(not shown). As observed previously by others [6,10], mitochon-
drial StarD1 and plasma membrane ABCA1 were strongly upregu-
lated in RAW cells after several hours of db-cAMP treatment.
ABCA1 expression was shown to be dependent on StarD1 because
knockdown of the latter attenuated the former during cell stimula-
tion. Cytosolic StarD4 was also shown to be upregulated during
stimulation, which appears not to have been reported previously.
In an earlier study (16), we showed that recombinant StarD4 could
bind liposomal 7a-OOH and accelerate its transfer to isolatedmitochondria, where peroxide-induced free radical damage/dys-
function ensued. Since a sterol-speciﬁc binding pocket exists in
most StAR-family proteins (7), it is likely that binding therein
was necessary for the 7a-OOH effects observed in the present
study. Collectively, these observations support our hypothesis that
in vascular macrophages under elevated oxidative pressure, StarD4
and StarD1 will transport ChOOHs from imported LDLox and/or
pre-existing pools to/into mitochondria along with cholesterol,
thereby causing internal mitochondria damage. Such damage
would disrupt RCT by inhibiting CYP27A1-catalzyed 27-OH gener-
ation and thence ABCA1 and ABCG1 induction because 27-OH is a
key activator of nuclear LXR, which controls expression of these
cholesterol exporters [3–5].
We recently described an analogous mitochondria damage/dys-
function mechanism for steroidogenically-activated MA-10 Leydig
cells challenged with 7a-OOH [18]. In that case, we also observed
StarD1-dependent transport of 7a-OOH into mitochondria with a
concomitant loss of DWm. Moreover, mitochondria-dependent
metabolism of cholesterol to progesterone was markedly impaired.
Whereas activated MA-10 cells died exclusively by intrinsic apop-
tosis, non-activated controls died by necrosis, consistent with 7a-
OOH delivery to mitochondria in the former case. Preliminary data
(not shown) suggested that 7a-OOH-induced death of activated
RAW cells (Fig. 6) also occurred via intrinsic apoptosis.
In summary, we have identiﬁed a unique mechanism by which
stress-generated ChOOHs (represented here by 7a-OOH) can dam-
age and disable macrophages. This introduces a new paradigm of
how a particular class of oxysterols, i.e. redox-active ChOOHs that
are recognized and transported by StAR family proteins, can inca-
pacitate RCT and thus act to promote atherogenesis [2,22]. One
may consider this inauspicious transport to be ‘‘stealthy’’ or ‘‘Tro-
jan Horse’’-like. A mitochondria-targeted antioxidant such as mito-
chondria-Q, which is being clinically evaluated for other purposes
[23], may prove useful for suppressing the damage/dysfunction we
describe, but this remains to be investigated.
Acknowledgments
This work was supported by Polish National Science Center
Grant 2011/01/B/NZ3/02167 and Medical College of Wisconsin Re-
search Affairs Committee Grant 3726 (to W.K.) and by National
Institutes of Health Grant HL85677 (to A.W.G). We thank Dr. Jerzy
Dobrucki for making the confocal microscope available in the Lab-
oratory of Cell Biophysics.
References
[1] Krieger, M., Acton, S., Ashkenas, J., Pearson, A., Penman, M. and Resnick, D.
(1993) Molecular ﬂypaper, host defense, and atherogenesis: structure, binding
properties, and functions of macrophage scavenger receptors. J. Biol. Chem.
268, 4569–4572.
[2] Stocker, R. and Keaney, J.F. (2005) New insights on oxidative stress in the
artery wall. J. Thromb. Haemost. 3, 1825–1834.
[3] Ohashi, R., Mu, H., Wang, X., Yao, Q. and Chen, C. (2005) Reverse cholesterol
transport and cholesterol efﬂux in atherosclerosis. Q. J. Med. 98, 845–856.
[4] Cuchel, M. and Rader, D.J. (2006) Macrophage reverse cholesterol transport:
key to the regression of atherosclerosis? Circulation 113, 2548–2555.
[5] Escher, G., Krozowski, Z., Croft, K.D. and Sviridov, C. (2003) Expression of sterol
27-hydroxylase (CYP27A1) enhances cholesterol efﬂux. J. Biol. Chem. 278,
11015–11019.
[6] Borthwick, F., Taylor, J.M., Bartholomew, C. and Graham, A. (2009) Differential
regulation of the StarD1 subfamily of START lipid trafﬁcking proteins in
human macrophages. FEBS Lett. 583, 1147–1153.
[7] Tsujishita, Y. and Hurley, J.H. (2000) Structure and lipid transport mechanism
of a StAR-related domain. Nat. Struct. Biol. 7, 408–414.
[8] Cavelier, C., Lorenzi, I., Rohrer, L. and von Eckardstein, A. (2006) Lipid efﬂux by
the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys.
Acta 1761, 655–666.
[9] Zhao, Y., Van Berkel, T.J.C. and Van Eck, M. (2010) Relative roles of various
efﬂux pathways in net cholesterol efﬂux from macrophage foam cells in
atherosclerotic lesions. Curr. Opin. Lipidol. 21, 441–453.
70 W. Korytowski et al. / FEBS Letters 588 (2014) 65–70[10] Ma, Y., Ren, S., Pandak, W.M., Li, X., Ning, Y., Lu, C., Zhao, F. and Yin, L. (2007)
The effects of inﬂammatory cytokines on steroidogenic acute regulatory
protein expression in macrophages. Inﬂamm. Res. 56, 495–501.
[11] Soccio, R.E., Adams, R.M., Maxwell, K.N. and Breslow, J.L. (2005) Differential
gene regulation of StarD4 and StarD5 cholesterol transfer proteins. J. Biol.
Chem. 280, 19410–19418.
[12] Girotti, A.W. (1998) Lipid hydroperoxide generation, turnover, and effector
action in biological systems. J. Lipid Res. 39, 1529–1542.
[13] Girotti, A.W. (2008) Translocation as a means of disseminating lipid
hydroperoxide-induced oxidative damage and effector action. Free Radic.
Biol. Med. 44, 956–968.
[14] Vila, A., Levchenko, V.V., Korytowski, W. and Girotti, A.W. (2004) Sterol carrier
protein-2-facilitated intermembrane transfer of cholesterol- and
phospholipid-derived hydroperoxides. Biochemistry 43, 12592–12605.
[15] Kriska, T., Levchenko, V.V., Korytowski, W., Atshaves, B.P., Schroeder, F. and
Girotti, A.W. (2006) Intracellular dissemination of peroxidative stress:
internalization, transport and lethal targeting of a cholesterol hydroperoxide
species by sterol carrier protein-2-overexpressing hepatoma cells. J. Biol.
Chem. 281, 23643–23651.
[16] Korytowski, W., Rodriguez-Agudo, D., Pilat, A. and Girotti, A.W. (2010) StarD4-
mediated translocation of 7-hydroperoxycholesterol to isolated mitochondria:
deleterious effects and implications for steroidogenesis under oxidative stress
conditions. Biochem. Biophys. Res. Commun. 392, 58–62.
[17] Korytowski, W., Geiger, P.G. and Girotti, A.W. (1999) Lipid hydroperoxide
analysis by high-performance liquid chromatography with mercury cathode
electrochemical detection. Methods Enzymol. 300, 23–33.[18] Korytowski, W., Pilat, A., Schmitt, J.C. and Girotti, A.W. (2013) Deleterious
cholesterol hydroperoxide trafﬁcking in steroidogenic acute regulatory (StAR)
protein-expressing MA-10 Leydig cells: implications for oxidative stress-
impaired steroidogenesis. J. Biol. Chem. 288, 11509–11519.
[19] Drummen, G.P.C., van Liebergen, L.C., Op den Kamp, J.A. and Post, J.A. (2002)
C11-BODIPY(581/591), an oxidation-sensitive ﬂuorescent lipid peroxidation
probe: (micro)spectroscopic characterization and validation of methodology.
Free Radic. Biol. Med. 33, 473–490.
[20] Chisolm, G.M., Ma, G., Irwin, K.C., Martin, L.L., Gunderson, K.G., Linberg, L.G.,
Morel, D.W. and DiCorleto, P.E. (1994) 7-b-Hydroperoxycholest-5-en-3b-ol, a
component of human atherosclerotic lesions, is the primary cytotoxin of
oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA 91, 11452–
11456.
[21] Brown, A.J., Leong, S., Dean, R.T. and Jessup, W. (1997) 7-
Hydroperoxycholesterol and its products in oxidized low density lipoprotein
and human atherosclerotic plaque. J. Lipid Res. 38, 1730–1745.
[22] Shibata, N. and Glass, C.K. (2010) Macrophages, oxysterols and atherosclerosis.
Circ. J. 74, 2045–2051.
[23] Snow, B.J., Rolfe, F.L., Lockhart, M.M., Frampton, C.M., O’Sullivan, J.D., Fung, V.,
Smith, R.A., Murphy, M.P. and Taylor, K.M. (2010) A double-blind, placebo-
controlled study to assess the mitochondria-targeted antioxidant
mitochondria-Q as a disease-modifying therapy in Parkinson’s disease. Mov.
Disord. 25, 1670–1674.
